snappi receives banking license from the European Central Bank (Di venerdì 28 giugno 2024)
IOANNINA, Greece, June 28, 2024 /PRNewswire/
snappi, the pioneering Greek neoBank, announces that it has received a universal Banking license from the European Central Bank (ECB), following the proposal of the Bank of Greece. The regulator's approval comes as the first milestone in snappi's plans to provide next-generation financial services. The licensing process was facilitated by snappi's experienced team, working in strong collaboration with regulatory authorities. With the full Banking license, snappi is authorized to conduct a comprehensive range of Banking activities, including accepting deposits and offering loans. Christos Megalou, Chairman of snappi's Board of Directors and CEO of Piraeus Bank, remarked: "I am very pleased that snappi has been granted a Eurozone-passportable Banking license.Leggi tutta la notizia su liberoquotidiano
Notizie su altre fonti
snappi, the pioneering Greek neoBank, announces that it has received a universal Banking license from the European Central Bank (ECB), following the proposal of the Bank of Greece. The regulator's approval comes as the first milestone in snappi's plans to provide next-generation financial services. The licensing process was facilitated by snappi's experienced team, working in strong collaboration with regulatory authorities. With the full Banking license, snappi is authorized to conduct a comprehensive range of Banking activities, including accepting deposits and offering loans. Christos Megalou, Chairman of snappi's Board of Directors and CEO of Piraeus Bank, remarked: "I am very pleased that snappi has been granted a Eurozone-passportable Banking license.Leggi tutta la notizia su liberoquotidiano
- snappi receives banking license from the European Central Bank - PRNewswire/ -- snappi, the pioneering Greek neobank, announces that it has received a universal banking license from the European Central bank (ECB), following the proposal of the bank of Greece. The ... adnkronos
- BridGene Biosciences Announces Dosing of First Patient in Phase 1 Study Evaluating Novel TEAD Inhibitor BGC515 in Advanced Solid Tumors - BridGene Biosciences, Inc., a leader in developing covalent small molecule drugs for traditional "hard-to-drug" targets, announced today that the first patient has been dosed in its Phase 1 clinical ... lelezard
- Intermap Technologies Announces Voting Results of the Annual Meeting of Shareholders - Intermap Technologies Corporation ("Intermap" or the "Company") held its annual shareholders meeting (the "Meeting") on June 27, 2024, at the TMX Market Centre, Bourse Room, located at 120 Adelaide St ... lelezard
Video snappi receives
Video snappi receives
Facebook
Tik Tok
Twitter
Instagram
You Tube
Iscriviti
